CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,000 | -51.9% | 1,500 | -25.0% | 0.01% | -55.2% |
| Q4 2017 | $52,000 | +246.7% | 2,000 | +100.0% | 0.03% | +222.2% |
| Q3 2017 | $15,000 | +7.1% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $14,000 | -46.2% | 1,000 | -33.3% | 0.01% | -43.8% |
| Q1 2017 | $26,000 | +23.8% | 1,500 | -25.0% | 0.02% | +23.1% |
| Q4 2016 | $21,000 | +5.0% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $20,000 | +17.6% | 2,000 | +33.3% | 0.01% | +8.3% |
| Q2 2016 | $17,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |